Table 3. Model results: cost outcomes.

	Intervention	Comparator
	2nd Gen DAA n = 1000	1st Gen DAA + not treated n = 500 + 500	1st Gen DAA n = 1000	Not treated n = 1000
Per patient total treatment cost*	$131,398	$165,101	$170,305	$159,897
Cost per SVR12	$117,331	N/A	$187,058	N/A
Per patient monitoring cost	$944.75	$2,116	$4,232	$0
Total budget impact (mn)	$131.4	$165.1	N/A	N/A
ICER	Dominant	Referent	N/A	N/A

^*Product prices reflect wholesale acquisition cost and physician reimbursement costs are per the United States Centers for Medicare and Medicaid Services fee schedule.

Abbreviations: SVR12, sustained viral response 12 weeks after end of treatment; mn, million; ICER, incremental cost-effectiveness ratio.